DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma

Somatic mutations in the EGFR proto-oncogene occur in ~15% of human lung adenocarcinomas and the importance of EGFR mutations for the initiation and maintenance of lung cancer is well established from mouse models and cancer therapy trials in human lung cancer patients. Recently, we identified DOK2...

Full description

Saved in:

Bibliographic Details
Main Authors:	Berger, Alice H., Chen, Ming, Morotti, Alessandro, Janas, Justyna A., Niki, Masaru, Bronson, Roderick T., Taylor, Barry S., Ladanyi, Marc, Van Aelst, Linda, Politi, Katerina, Varmus, Harold E., Pandolfi, Pier Paolo
Format:	Artigo
Language:	Inglês
Published:	Public Library of Science 2013
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3821857/ https://ncbi.nlm.nih.gov/pubmed/24255704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0079526
Tags:	Add Tag No Tags, Be the first to tag this record!

DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma

Similar Items